Refine by
Cardiac Support Articles & Analysis
18 news found
(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...
(PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...
Jorde, MD, professor of medicine, Albert Einstein College of Medicine, and section head of Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support at Montefiore Health System in New York, and global co-principal investigator of the CORCINCH-HF ...
This is important because the two essential requirements of cardiac stents- to support the vessel during the healing process and to deliver drugs to prevent restenosis-are temporary needs. ...
Stratus offers technology, services, and proprietary software solutions to help neurologists accurately and quickly diagnose their patients with epilepsy and other seizure-like disorders. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology ...
Wendt has rigorously captured the outcomes of these patients and to date has contributed over 10 scientific papers describing the benefits of CytoSorb use in cardiac surgery. In his role, Dr. Wendt will be responsible for all cardiovascular medical affairs activities in support of the CE Mark approved uses of CytoSorb in cardiac surgery and will ...
The final results of the 60-day experience, presented at the ESAO conference, confirm the CorWave pump’s ability to provide chronic circulatory support with outstanding hemocompatibility. Dr. Snyder explained, “We were thrilled by the performance of the pump. ...
ByCorWave
Schmitto, Director of the Mechanical Circulatory Support and Cardiac Transplantation Program at Hannover Medical School, declared: “The implant of the first CARMAT TAH in Germany represents another milestone in the field of Mechanical Circulatory Support Devices. ...
ByCarmat
“We are very proud to have supported Professor Wildhirt and his team to reach critical R&D goals and the required and investment to enable them to enter the clinical arena. Therefore, we gladly also further support their efforts with the follow-up investment. Their continued commitment and hard work to want to better serve this large community of ...
Professor Stephan Schueler, Head of Mechanical Circulation Support at the Newcastle upon Tyne Freeman Hospital, UK, will be presenting the latest preclinical data, taking a deep dive focus on the impact of precise electro-mechanical synchronization on haemodynamic performance. ...
“As far as we can determine, there has never before been any active, extra-cardiac device for mechanical circulatory support that has demonstrated 30- and 60-day pre-clinical survival. ...
” “Heart failure is a chronic and progressive condition that often worsens past the clinical effectiveness of existing treatments, leaving patients with few options as their disease advances,” said Ulrich Jorde, MD, co-principal investigator of the CorCinch-HF pivotal study; professor of medicine, Albert Einstein College of Medicine; and section head of Heart Failure, ...
The presentation unveils the latest results of the preclinical evaluation of CorWave’s cardiac support device, validating the hemocompatibility, durability and hemodynamic performance of the LVAD. ...
ByCorWave
The wearables provide continuous monitoring of the cardiac systems and blood pressure. Supported by traditional electrocardiogram (ECG) verification, what makes the CardiacSense wearable different is that it uses PPG technology (photoplethysmography) that is free of any movement artifacts (which are the Achilles Heel of traditional PPG) to carry out long-term, ...
The first application of the biomimetic polymer will be the printing of a novel surface for an extravascular cardiac support system. The system of the Munich-based AdjuCor GmbH is based on a patient-specific mechanical implant, which is positioned completely outside the blood flow (extravascular) in the pericardial cavity around the epicardial surface of both ...
“Because heart failure is a progressive disease, medication therapy can become less effective over time, leaving patients with few treatment options as their condition worsens,” said Ulrich Jorde, MD, co-principal investigator of the CorCinch HFrEF study and section head of Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support at ...
Apart from other achievements, the study confirmed the chronic physiologic acceptance of their non-blood-contacting biventricular cardiac support device by the body. AdjuCor has previously completed a successful 30-day in vivo study. ...
” Prof. Stephan Schueler, Director of Cardiac Transplant and Assist Device Therapy at Freeman Hospital in Newcastle upon Tyne, UK pointed out that many obstacles in current assist device therapy are directly linked to foreign surfaces contacting the blood stream. ...